Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Takayasu's arteritis and its therapy.

J H Shelhamer, D J Volkman, J E Parrillo

    Annals of Internal Medicine
    |July 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The management of subglottic stenosis in patients with Wegener's granulomatosis.

    The Laryngoscope·1992
    Same author

    The treatment of Wegener's granulomatosis with glucocorticoids and methotrexate.

    Arthritis and rheumatism·1992
    Same author

    Interferon gamma induces the expression of human immunodeficiency virus in persistently infected promonocytic cells (U1) and redirects the production of virions to intracytoplasmic vacuoles in phorbol myristate acetate-differentiated U1 cells.

    The Journal of experimental medicine·1992
    Same author

    CD34+ bone marrow cells are infected with HIV in a subset of seropositive individuals.

    Journal of immunology (Baltimore, Md. : 1950)·1992
    Same author

    Lymphokine production by B cells from normal and HIV-infected individuals.

    Annals of the New York Academy of Sciences·1992
    Same author

    Pharmacologic regulation of HIV expression.

    AIDS research and human retroviruses·1992

    Glucocorticosteroids were effective for some Takayasu arteritis patients, but cyclophosphamide and surgery offered additional benefits for those with active inflammation or progression. Combined therapies prevented deaths in this vasculitis cohort.

    Area of Science:

    • Rheumatology
    • Vascular Medicine
    • Immunology

    Background:

    • Takayasu arteritis is a rare, chronic inflammatory condition affecting large arteries.
    • Management often involves immunosuppressants and surgical interventions.
    • Long-term outcomes and treatment efficacy require further investigation.

    Purpose of the Study:

    • To evaluate the long-term efficacy of glucocorticosteroids, cyclophosphamide, and surgical reconstruction in Takayasu arteritis.
    • To assess treatment outcomes and complications in patients with active vasculitis.

    Main Methods:

    • Prospective follow-up of 20 Takayasu arteritis patients over an average of 4.6 years.
    • Treatment with glucocorticosteroids, followed by cyclophosphamide for non-responders.
    • Vascular reconstructive surgery was performed in select patients.

    Related Experiment Videos

    Main Results:

    • Eight of 16 patients responded to initial glucocorticosteroid therapy.
    • Four of 6 patients on cyclophosphamide showed no disease progression.
    • Vascular surgery was successful in 7 patients with no major complications; one graft occlusion was revised.

    Conclusions:

    • Glucocorticosteroids provide initial benefit for some, but additional therapies are needed for refractory cases.
    • Cyclophosphamide and vascular surgery are valuable adjuncts in managing Takayasu arteritis.
    • Multimodal treatment strategies can prevent mortality in Takayasu arteritis.